George Dangas, MD, PhD Email George Dangas
- PROFESSOR | Medicine, Cardiology
- PROFESSOR | Surgery
- Cardiovascular Disease
- Interventional Cardiology
- Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Book an Appointment - George Dangas, MD, PhD
George D. Dangas, MD, PhD is Professor of Medicine at the Mount Sinai School of Medicine and Director of Cardiovascular Innovation at the Zena and Michael A. Weiner Cardiovascular Institute of the Mount Sinai Medical Center in New York City.
Dr. Dangas is a leading authority in the performance of nonsurgical cardiac and vascular interventions (e.g. stent, angioplasty, atherectomy) using both established and novel techniques and in preventing and dissolving thrombosis in the coronary and peripheral arteries. He is currently serving as the Chair of the American College of Cardiology Interventional Scientific Council and has been a Trustee of the Society for Cardiovascular Angiography & Interventions (SCAI). He has been a co-director of the annual conferences Transcatheter Cardiovascular Therapeutics and Interventional Fellows’ Courses in the USA and Europe for many years and key faculty and program committee member for multiple international conferences including the ACCi2 Summit, ACCIS, and SCAI. He is also the Director of Academic Affairs at the Cardiovascular Research Foundation.
Dr. Dangas completed medical and postgraduate studies at the National Kapodistrian University of Athens, Greece. Dr. Dangas completed his internship and residency in internal medicine at Miriam Hospital and Brown University in Providence, Rhode Island. He completed his cardiovascular disease and interventional cardiology fellowships at Mount Sinai Hospital, New York City. Before joining the Faculty of Mount Sinai, he has been Associate Professor and Program Director of Interventional Cardiology at Columbia University Medical Center, NYC and Associate Clinical Professor at NYU School of Medicine and Lenox Hill Hospital. He has been certified by the American Board of Internal Medicine in Cardiovascular Disease and Interventional Cardiology, by the American Board of Vascular Medicine in both Endovascular and Vascular Medicine, and has been elected Fellow of seven national and international professional societies (AHA, ACC, ACCP, ESC, SCAI, ACP-ASIM, SVM).
In The News: Dr. George Dangas discusses lowering the risks for cardiovascular disease in the Daily News feature, The Daily Check Up.
- Acute Coronary Syndrome
- Annual Physical
- Aortic Aneurysm
- Aortic Disease
- Aortic Insufficiency
- Aortic Stenosis
- Arrhythmia Diagnostic
- Atherectomy/Angioplasty Of Noncoronary Vessel
- Atrial Fibrillation
- Bypass Surgery Consultation - CABG
- Cardiac Catheterization
- Cardiac Tamponade
- Cardiac Tumor
- Cardiology Second Opinion
- Cardiovascular Distress
- Carotid Artery Stenosis
- Chest Pain
- Congestive Heart Failure
- Coronary Angiography
- Coronary Artery Disease
- Coronary Stenting
- ECG / EKG
- Heart Strengthening / Recovery
- Heart Transplant
- Holter Monitor
- Hypertrophic Cardiomyopathy
- Minimally Invasive Bypass Consultation - OPCAB
- Mitral Regurgitation
- Mitral Stenosis
- Percutaneous Balloon Valvuloplasty
- Peripheral Vascular Disease
- Radiofrequency Ablation
- Renal Artery Stenosis
MD, University of Athens
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Interventional Cardiology
Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Dangas during 2018 and/or 2019. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- GE HealthCare
- Janssen Pharmaceuticals, Inc.
- Medtronic, Inc.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Claret Medical Inc.
- Elixir Medical Corporation
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- The Medicines Company
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.